Clinical trial
Dendritic Cell Based Therapy of Malignant Melanoma
NCT00197912 · Herlev Hospital, Other · Completed
Key facts
| NCT number | NCT00197912 |
|---|---|
| Title | Dendritic Cell Based Therapy of Malignant Melanoma |
| Official title | Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Malignant Melanoma. Phase I/II Study |
| Lead sponsor | Herlev Hospital, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Melanoma |
| Intervention type | Biological |
| Interventions | tumor antigen loaded autologous dendritic cells |
| Enrollment | 25 |
| Start date | Sep 1, 2004 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 26, 2010 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: